Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index

INTRODUCTION: Transcatheter arterial chemoembolization (TACE) is the first-line treatment for intermediate stage hepatocellular carcinoma (HCC) and prolongs survival in HCC patients. However, repeated TACE results in diminished therapeutic response. In addition, the superiority of sorafenib to TACE...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Adv Ther
Glavni autori: Ohki, Takamasa, Kondo, Mayuko, Karasawa, Yuki, Kawamura, Satoshi, Maeshima, Shuuya, Kojima, Kentaro, Seki, Michiharu, Toda, Nobuo, Shioda, Yoshinobu, Tagawa, Kazumi
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2017
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5427139/
https://ncbi.nlm.nih.gov/pubmed/28389996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-017-0524-9
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items